Definitive Healthcare (NASDAQ:DH) Posts Earnings Results, Hits Expectations

Definitive Healthcare (NASDAQ:DH) posted its quarterly earnings data on Monday. The company reported $0.09 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.09, Briefing.com reports. The company had revenue of $63.70 million for the quarter, compared to analyst estimates of $63.19 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. The business’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.08 earnings per share. Definitive Healthcare updated its Q3 guidance to $0.07-0.08 EPS.

Definitive Healthcare Stock Performance

Shares of DH traded up $0.18 during midday trading on Wednesday, hitting $3.83. 2,617,498 shares of the stock traded hands, compared to its average volume of 824,852. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $11.44. The firm has a market capitalization of $451.69 million, a PE ratio of -2.19, a price-to-earnings-growth ratio of 4.58 and a beta of 1.30. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.30 and a current ratio of 2.30. The business’s 50 day moving average price is $5.37 and its two-hundred day moving average price is $6.96.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on DH. Morgan Stanley dropped their price target on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a research note on Tuesday. Stifel Nicolaus dropped their price target on shares of Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating for the company in a research note on Wednesday, July 31st. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Definitive Healthcare from $10.00 to $7.00 and set a “hold” rating for the company in a research note on Thursday, May 9th. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Tuesday. Finally, JPMorgan Chase & Co. downgraded shares of Definitive Healthcare from a “neutral” rating to an “underweight” rating and decreased their price objective for the stock from $7.00 to $5.00 in a report on Wednesday, July 31st. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $7.75.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.